From inflammation to sickness and depression: when the immune system subjugates the brain (original) (raw)

• Dantzer, R. & Kelley, K. W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 21, 153–160 (2007).
  Article CAS PubMed Google Scholar
• Hart, B. L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12, 123–137 (1988). The original description of sickness behaviour, its relationship with fever and adaptive value.
  Article CAS PubMed Google Scholar
• Dantzer, R. & Kelley, K. W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44, 1995–2008 (1989).
  Article CAS PubMed Google Scholar
• Dantzer, R. Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15, 7–24 (2001).
  Article CAS PubMed Google Scholar
• Steptoe, A. (ed.) Depression and Physical Illness (Cambridge University Press, Cambridge, 2007).
  Google Scholar
• Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12–18 (2007). A review of how the brain immune response differs from that in other organs.
  Article CAS PubMed Google Scholar
• Dantzer, R. in Psychoneuroimmunology (ed. Ader, R.) 271–280 (Elsevier, Amsterdam, 2007).
  Book Google Scholar
• Bluthe, R. M. et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C. R. Acad. Sci. III 317, 499–503 (1994). The first demonstration that section of the vagus nerves blocks immune-to-brain communication and abrogates lipopolysacccharide-induced sickness behaviour without compromising the peripheral immune response.
  CAS Google Scholar
• Watkins, L. R. et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639, 283–299 (1994).
  Article CAS PubMed Google Scholar
• Romeo, H. E., Tio, D. L., Rahman, S. U., Chiappelli, F. & Taylor, A. N. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J. Neuroimmunol. 115, 91–100 (2001).
  Article CAS PubMed Google Scholar
• Quan, N., Whiteside, M. & Herkenham, M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83, 281–293 (1998).
  Article CAS PubMed Google Scholar
• Vitkovic, L. et al. Cytokine signals propagate through the brain. Mol. Psychiatry 5, 604–615 (2000).
  Article CAS PubMed Google Scholar
• Banks, W. A. The blood-brain barrier in psychoneuroimmunology. Neurol. Clin. 24, 413–419 (2006).
  Article PubMed Google Scholar
• Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A. & Blomqvist, A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 472, 113–129 (2004).
  Article PubMed Google Scholar
• Schiltz, J. C. & Sawchenko, P. E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 22, 5606–5618 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Dantzer, R., Konsman, J. P., Bluthe, R. M. & Kelley, K. W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton. Neurosci. 85, 60–65 (2000).
  Article CAS PubMed Google Scholar
• Reyes, T. M. & Sawchenko, P. E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J. Neurosci. 22, 5091–5099 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ericsson, A., Kovacs, K. J. & Sawchenko, P. E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14, 897–913 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Dinarello, C. A. Interleukin-1. Cytokine Growth Factor Rev. 8, 253–265 (1997).
  Article CAS PubMed Google Scholar
• Parnet, P., Kelley, K. W., Bluthe, R. M. & Dantzer, R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J. Neuroimmunol. 125, 5–14 (2002).
  Article CAS PubMed Google Scholar
• van Dam, A. M., Brouns, M., Louisse, S. & Berkenbosch, F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588, 291–296 (1992). The first demonstration that peripherally administered lipopolysaccharide induces the expression of IL-1β in the brain.
  Article CAS PubMed Google Scholar
• Laye, S., Parnet, P., Goujon, E. & Dantzer, R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 27, 157–162 (1994).
  Article CAS PubMed Google Scholar
• Quan, N., Stern, E. L., Whiteside, M. B. & Herkenham, M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. 93, 72–80 (1999).
  Article CAS PubMed Google Scholar
• Gatti, S. & Bartfai, T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624, 291–294 (1993).
  Article CAS PubMed Google Scholar
• Breder, C. D. et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl Acad. Sci. USA 91, 11393–11397 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Carmichael, M. D. et al. Role of brain IL-1beta on fatigue after exercise-induced muscle damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1344–1348 (2006).
  Article CAS PubMed Google Scholar
• Ohdo, S., Koyanagi, S., Suyama, H., Higuchi, S. & Aramaki, H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nature Med. 7, 356–360 (2001).
  Article CAS PubMed Google Scholar
• Cavadini, G. et al. TNF-{alpha} suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl Acad. Sci. USA (2007).
• Sparkman, N. L. et al. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. 26, 10709–10716 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Heyen, J. R., Ye, S., Finck, B. N. & Johnson, R. W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77, 138–147 (2000).
  Article CAS PubMed Google Scholar
• Strle, K. et al. Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGFI in myoblasts. J. Neuroimmunol. (in the press).
• Bluthe, R. M. et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24, 301–311 (1999).
  Article CAS PubMed Google Scholar
• Dantzer, R., Gheusi, G., Johnson, R. W. & Kelley, K. W. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. Neuroreport 10, 289–292 (1999).
  Article CAS PubMed Google Scholar
• Bluthe, R. M., Kelley, K. W. & Dantzer, R. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav. Immun. 20, 57–63 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Leon, L. R., Kozak, W., Rudolph, K. & Kluger, M. J. An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 276, R81–89 (1999).
  CAS PubMed Google Scholar
• Ye, S. M. & Johnson, R. W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93, 139–148 (1999).
  Article CAS PubMed Google Scholar
• Ye, S. M. & Johnson, R. W. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9, 183–192 (2001).
  Article CAS PubMed Google Scholar
• Huang, Y., Henry, C. J., Dantzer, R., Johnson, R. W. & Godbout, J. P. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging (2007).
• O'Connor, J. C. et al. IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J. Immunol. 174, 4991–4997 (2005).
  Article CAS PubMed Google Scholar
• Yirmiya, R. et al. Cytokines, “depression due to a general medical condition” and antidepressant drugs. Adv. Exp. Med. Biol. 461, 283–316 (1999).
  Article CAS PubMed Google Scholar
• Raison, C. L., Capuron, L. & Miller, A. H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27, 24–31 (2006). An excellent review of the clinical features of cytokine-induced depression and its possible mechanisms.
  Article CAS PubMed Google Scholar
• Nemeroff, C. B. & Vale, W. W. The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry 66, Suppl 7, 5–13 (2005).
  CAS PubMed Google Scholar
• Smith, R. S. The macrophage theory of depression. Med. Hypotheses 35, 298–306 (1991).
  Article CAS PubMed Google Scholar
• Maes, M., Smith, R. & Scharpe, S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20, 111–116 (1995).
  Article CAS PubMed Google Scholar
• Irwin, M. R. & Miller, A. H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21, 374–383 (2007).
  Article CAS PubMed Google Scholar
• Denicoff, K. D. et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Intern. Med. 107, 293–300 (1987).
  Article CAS PubMed Google Scholar
• Renault, P. F. et al. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147, 1577–1580 (1987).
  Article CAS PubMed Google Scholar
• Capuron, L. et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643–652 (2002).
  Article CAS PubMed Google Scholar
• Capuron, L., Ravaud, A. & Dantzer, R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J. Clin. Oncol. 18, 2143–2151 (2000).
  Article CAS PubMed Google Scholar
• Constant, A. et al. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J. Clin. Psychiatry 66, 1050–1057 (2005).
  Article CAS PubMed Google Scholar
• Capuron, L. & Ravaud, A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N. Engl. J. Med. 340, 1370 (1999).
  Article CAS PubMed Google Scholar
• Capuron, L. et al. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 160, 1342–1345 (2003).
  Article PubMed Google Scholar
• Frenois, F. et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32, 516–531 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Simmons, D. A. & Broderick, P. A. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 793–807 (2005).
  Article CAS PubMed Google Scholar
• Merali, Z., Brennan, K., Brau, P. & Anisman, H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology (Berl.) 165, 413–418 (2003).
  Article CAS Google Scholar
• Capuron, L. et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 7, 468–473 (2002). A landmark paper demonstrating that repeated activation of the immune system by systemic administration of IL-2 and IFN-α to cancer patients induces a drastic fall in plasma tryptophan levels that is positively correlated to the depression scores.
  Article CAS PubMed Google Scholar
• Ruhe, H. G., Mason, N. S. & Schene, A. H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12, 331–359 (2007).
  Article CAS PubMed Google Scholar
• Wirleitner, B., Neurauter, G., Schrocksnadel, K., Frick, B. & Fuchs, D. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10, 1581–1591 (2003).
  Article CAS PubMed Google Scholar
• Lestage, J., Verrier, D., Palin, K. & Dantzer, R. The enzyme indoleamine 2, 3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 16, 596–601 (2002).
  Article CAS PubMed Google Scholar
• Moreau, M. et al. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2, 3-dioxygenase in mice. J. Infect. Dis. 192, 537–544 (2005).
  Article CAS PubMed Google Scholar
• Muller, N. & Schwarz, M. J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol. Psychiatry 12, 988–1000 (2007).
  Article CAS PubMed Google Scholar
• Dunn, A. J., Swiergiel, A. H. & de Beaurepaire, R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci. Biobehav. Rev. 29, 891–909 (2005).
  Article CAS PubMed Google Scholar
• Zhu, C. B., Blakely, R. D. & Hewlett, W. A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31, 2121–2131 (2006).
  Article CAS PubMed Google Scholar
• Cai, W. et al. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J. Hepatol. 42, 880–887 (2005).
  Article CAS PubMed Google Scholar
• Pariante, C. M. Depression, stress and the adrenal axis. J. Neuroendocrinol. 15, 811–812 (2003).
  Article PubMed Google Scholar
• Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F. & Besedovsky, H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238, 524–526 (1987).
  Article CAS PubMed Google Scholar
• Grinevich, V. et al. Hypothalamic pituitary adrenal axis and immune responses to endotoxin in rats with chronic adjuvant-induced arthritis. Exp. Neurol. 178, 112–123 (2002).
  Article CAS PubMed Google Scholar
• Swaab, D. F., Bao, A. M. & Lucassen, P. J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4, 141–194 (2005).
  Article CAS PubMed Google Scholar
• Holsboer, F. Corticotropin-releasing hormone modulators and depression. Curr. Opin. Investig. Drugs 4, 46–50 (2003).
  CAS PubMed Google Scholar
• Pace, T. W., Hu, F. & Miller, A. H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 21, 9–19 (2007).
  Article CAS PubMed Google Scholar
• Raison, C. L. & Miller, A. H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 160, 1554–1565 (2003).
  Article PubMed Google Scholar
• Fitzgerald, P. B., Laird, A. R., Maller, J. & Daskalakis, Z. J. A meta-analytic study of changes in brain activation in depression. Hum. Brain Mapp. (2007).
• Capuron, L. et al. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007).
• Capuron, L. et al. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol. Psychiatry 58, 190–196 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Stone, E. A., Lehmann, M. L., Lin, Y. & Quartermain, D. Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol. Psychiatry 60, 803–811 (2006).
  Article CAS PubMed Google Scholar
• Phillips, M. L., Drevets, W. C., Rauch, S. L. & Lane, R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol. Psychiatry 54, 515–528 (2003).
  Article PubMed Google Scholar
• Lowry, C. A. et al. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience 146, 756–772 (2007).
  Article CAS PubMed Google Scholar
• Craig, A. D. How do you feel? Interoception: the sense of the physiological condition of the body. Nature Rev. Neurosci. 3, 655–666 (2002).
  Article CAS Google Scholar
• Frasure-Smith, N. & Lesperance, F. Depression and coronary artery disease. Herz 31, Suppl 3, 64–68 (2006).
  PubMed Google Scholar
• Tyring, S. et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367, 29–35 (2006).
  Article CAS PubMed Google Scholar
• Muller, N. et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11, 680–684 (2006).
  Article CAS PubMed Google Scholar
• van den Biggelaar, A. H. et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp. Gerontol. 42, 693–701 (2007).
  Article CAS PubMed Google Scholar
• Godbout, J. P. et al. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology (in the press).
• Airan, R. D. et al. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317, 819–823 (2007).
  Article CAS PubMed Google Scholar
• Sheng, H. et al. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275, 6628–6635 (2000).
  Article CAS PubMed Google Scholar
• Babcock, T. A. & Carlin, J. M. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 12, 588–594 (2000).
  Article CAS PubMed Google Scholar
• Siegert, R. J. & Abernethy, D. A. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry 76, 469–475 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pollak, Y., Ovadia, H., Orion, E., Weidenfeld, J. & Yirmiya, R. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J. Neuroimmunol. 137, 94–99 (2003).
  Article CAS PubMed Google Scholar
• Pollak, Y., Ovadia, H., Orion, E. & Yirmiya, R. The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments. J. Neuroimmunol. 137, 100–108 (2003).
  Article CAS PubMed Google Scholar
• McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Med. 11, 335–339 (2005).
  Article CAS PubMed Google Scholar
• Miller, S. D., McMahon, E. J., Schreiner, B. & Bailey, S. L. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 1103, 179–191 (2007).
  Article CAS PubMed Google Scholar
• Johnson, D. R., O'Connor, J. C., Hartman, M. E., Tapping, R. I. & Freund, G. G. Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. J. Neurosci. 27, 1161–1166 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ohayon, M. M. The effects of breathing-related sleep disorders on mood disturbances in the general population. J. Clin. Psychiatry 64, 1195–1200; quiz, 1274–1276 (2003).
  Article PubMed Google Scholar
• Borson, S., Claypoole, K. & McDonald, G. J. Depression and chronic obstructive pulmonary disease: treatment trials. Semin. Clin. Neuropsychiatry 3, 115–130 (1998).
  CAS PubMed Google Scholar
• Schwarcz, R. The kynurenine pathway of tryptophan degradation as a drug target. Curr. Opin. Pharmacol. 4, 12–17 (2004).
  Article CAS PubMed Google Scholar
• Combrinck, M. I., Perry, V. H. & Cunningham, C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112, 7–11 (2002).
  Article CAS PubMed Google Scholar
• Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K. & Perry, V. H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275–9284 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Godbout, J. P. et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. Faseb J. 19, 1329–1331 (2005).
  Article CAS PubMed Google Scholar
• Schroder, K., Sweet, M. J. & Hume, D. A. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211, 511–524 (2006).
  Article CAS PubMed Google Scholar
• Perry, V. H., Cunningham, C. & Holmes, C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Rev. Immunol. 7, 161–167 (2007). A presentation of the concept of priming of the microglial compartment during chronic brain inflammation and its role in the exaggerated response to systemic infections.
  Article CAS Google Scholar
• Stichel, C. C. & Luebbert, H. Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells. Neurobiol. Aging (2006).
• Silverman, A. J., Sutherland, A. K., Wilhelm, M. & Silver, R. Mast cells migrate from blood to brain. J. Neurosci. 20, 401–408 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav. Immun. 12, 212–229 (1998).
• Vereker, E., O'Donnell, E. & Lynch, M. A. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20, 6811–6819 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Sweller, J. Cognitive load during problem solving: effects on learning. Cognitive Sci. 12, 257–285 (1988).
  Article Google Scholar
• Blum, D., Chtarto, A., Tenenbaum, L., Brotchi, J. & Levivier, M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17, 359–366 (2004).
  Article CAS PubMed Google Scholar